Regional Medical Lead, Rare Diseases

Overview

DKSH’s purpose is to enrich people’s lives. For 160 years, we have been marketing, selling, and distributing high-quality products and brands for multinational and Fortune 500 companies. Through our Business Units Consumer Goods, Healthcare, Performance Materials, and Technology, we deliver sustainable growth for our partners. We contribute to improving the quality of life for our employees and people in the local communities in which we operate.

Headquartered in Switzerland, DKSH is publicly listed and operates in 36 markets across Asia Pacific, Europe, and North America. We employ over 28,000 specialists and produced net sales of CHF 11.1 billion in 2024.

Lead medical strategy that elevates patient outcomes across Asia.

Join DKSH to shape and deliver the regional medical‑scientific strategy across the product lifecycle for Rare Diseases & Pain Management
. You’ll align country needs, mobilize cross‑functional teams, and convert scientific insights into actions that matter for patients, HCPs, and health systems.

• Own the regional medical plan end‑to‑end: plan, execute, and monitor medical activities across APAC, ensuring scientific integrity and country fit.
• Launch excellence & KPI governance: track and optimize medical launch KPIs, patient‑centric outcomes, and evidence plans.
• Evidence generation: lead Phase IV / post‑marketing and RWE initiatives in line with therapeutic priorities and budget.
• Medical education & advocacy: drive high‑impact scientific engagement and partnerships with medical experts, societies, and key institutions.
• Insight to action: synthesize medical/scientific insights to inform brand strategies, clinical content, and country activation.
• Compliance & collaboration: partner closely with Regulatory, Market Access, Commercial, and Country Medical to ensure ethical, compliant execution.

• Minimum 7 years of experience in pharmaceutical medical affairs & clinical research, relevant therapy area experience preferred.
• Minimum 4 years of medical strategic lead experience in country. Cluster / Regional experience is essential
• Advanced life‑science degree (e.g.,
  MD/MBBS, Pharm
  
  D, PhD
  , or equivalent) with strong Medical Affairs experience in APAC.
• Therapeutic depth in Rare Diseases and/or Pain Management
  ; proven record driving medical launch KPIs
  , evidence plans, and scientific engagement quality.
• Hands‑on experience with Phase IV/RWE
  , medical content development, and HCP/KOL engagement (societies, centers of excellence).
• Skilled at turning data into decisions; clear communicator who influences across functions and countries.
• English fluency required;
  Asian language proficiency (e.g., Thai, Malay/Bahasa, Mandarin) is an advantage.
• Comfort operating in a matrix with regional travel.

• Regional impact: Shape therapy strategy across multiple markets and see your work move real‑world outcomes.
• Breadth & growth: Full lifecycle exposure (pre‑launch to post‑marketing) and opportunities to lead cross‑market initiatives.
• Supportive culture: Collaborative teams, continuous development, and a purpose‑driven mission—
  delivering growth in Asia and beyond
  .

We welcome all qualified applicants. DKSH is an equal‑opportunity employer. Selection is based on skills, experience, and potential. Work authorization will follow local requirements. If you need adjustments during the process, let us know.

Apply now with your CV (and a brief overview of your Phase IV/RWE and medical launch achievements, if available).